Zacks Investment Research on MSN

Emergent Biosolutions (EBS) Beats Q3 Earnings and Revenue Estimates

Emergent Biosolutions (EBS) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of a loss of $0.12 per share. This compares to earnings of $1.37 per share a year ...

Investors in Emergent BioSolutions (NYSE:EBS) have unfortunately lost 90% over the last five years

Emergent BioSolutions Inc. ( NYSE:EBS ) shareholders will doubtless be very grateful to see the share price up 56% ...

Emergent BioSolutions Inc. (NYSE:EBS) Q3 2025 Earnings Call Transcript

Q3 2025 Earnings Call Transcript October 29, 2025 Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is ...

Emergent Biosolutions Inc. (EBS) Soars to 52-Week High, Time to Cash Out?

Emergent Biosolutions (EBS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Emergent Biosolutions: Q3 Earnings Snapshot

GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Emergent Biosolutions Inc. (EBS) on Wednesday reported profit of $51.2 million in its third quarter. On a per-share basis, the Gaithersburg, ...

Emergent Biosolutions Q3 2025 Earnings Preview

Emergent Biosolutions (EBS) is scheduled to announce Q3 earnings results on Wednesday, October 29th, after market close. The consensus EPS Estimate is $0.11 (-9 ...